Provenance

Created by SPS and the Faculty of Sexual and Reproductive Health (FSRH), with the support of specialist stakeholders working within clinical practice, for contraception commonly supplied or administered within reproductive services.

Templates available

Version 2.0 of this PGD template has been published for organisations to take through relevant local governance processes ahead of the expiry of previous published template.

Version 2.0 is valid for use from the April 2023 when the current template expires.

Templates will be removed from the SPS website on expiry.

PGD template attachment

The template PGD is attached below to download and use in conjunction with our implementation advice.

• CHC ring National PGD template V1.3b March 2022 · Word · 185 KB
• CHC ring National PGD V2 FINAL Jan 23 · Word · 194 KB

More reproductive health PGD templates

• Lidocaine 10mg/ml spray for IUC: template protocol
• Topical lidocaine 2.5% plus prilocaine 2.5% cream for IUC: template protocol
• Insertion of the Progestogen-Only Intra-Uterine System (IUS): PGD template
• Supply and/or administration of subcutaneous medroxyprogesterone acetate (SC-DMPA) injection: PGD template
• Administration of intramuscular (IM) medroxyprogesterone acetate (DMPA) injection: PGD template
• Supply of a progestogen only contraceptive pill (POP): PGD template
• Supply of combined hormonal contraceptive transdermal patch: PGD template
• Supply of a combined oral hormonal contraceptive (COC): PGD template
• Supply and/or administration of ulipristal acetate 30mg tablet for emergency contraception: PGD template
• Supply and administration of levonorgestrel 1500 micrograms tablets for emergency contraception: PGD template
• Insertion of etonogestrel (e.g. Nexplanon®) 68mg subdermal implant for contraception: PGD template
• Administration of lidocaine injection to facilitate insertion and/or removal of subdermal etonogestrel (e.g. Nexplanon®) implant: PGD template

All PGD templates

Update history